1. Current alternative therapies for treating drug-resistant Neisseria gonorrhoeae causing ophthalmia neonatorum.
- Author
-
Belagal P
- Subjects
- Humans, Infant, Newborn, Complementary Therapies methods, Fatty Acids metabolism, Antimicrobial Peptides pharmacology, Ophthalmia Neonatorum drug therapy, Ophthalmia Neonatorum microbiology, Neisseria gonorrhoeae drug effects, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents pharmacology, Gonorrhea drug therapy, Gonorrhea microbiology, Drug Resistance, Bacterial
- Abstract
Ophthalmia neonatorum is a microbial contraction, damaging eyesight, occurring largely among neonates. Infants are particularly vulnerable to bacterial infections acquired during birth from infected mothers, especially from Neisseria gonorrhoeae and Chlamydia trachomatis . Over the decades, N. gonorrhoeae is alarmingly developing a resistance to most antibiotics currently prescribed. To counter this challenge, it is imperative to find potent and cost-effective therapeutic agents for prophylaxis and treatment, to which the N. gonorrhoeae cannot easily develop resistance. This review showcases alternate therapies such as antimicrobial-fatty acids, -peptides, -nano-formulations etc., currently evident against N. gonorrhoeae -mediated ophthalmia neonatorum, which remains a major cause of ocular morbidity, blindness and even death among neonates in developing countries.
- Published
- 2024
- Full Text
- View/download PDF